Company intelligence / Profile preview

Nebius Group

Amsterdam, Netherlandsgroup.nebius.com ↗

Ownership: Private
Employees: ~1300
Development stage: Other

Overview

Nebius Group operates a leading European-based AI-centric cloud platform optimized for intensive workloads in artificial intelligence. The company’s technology underpins high-performance computing needs in sectors including life sciences and healthcare by enabling large-scale genomics analysis, drug discovery modeling, and clinical data processing. It does not develop therapeutics itself but powers biotech/pharma innovation through its infrastructure.

Industry: Drug Discovery Services

Partnerships

NvidiaNumerous collaborations with biotech startups via the annual "AI Discovery Award" program

Beyond the preview

Go deeper on Nebius Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nebius Group.

Explore the full profile